Oragenics (OGEN) Competitors $0.29 +0.00 (+1.03%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.28 0.00 (-0.95%) As of 02/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends OGEN vs. BMRA, TRIB, CING, CRVO, ACXP, IMNN, PHIO, SNSE, FLGC, and TXMDShould you be buying Oragenics stock or one of its competitors? The main competitors of Oragenics include Biomerica (BMRA), Trinity Biotech (TRIB), Cingulate (CING), CervoMed (CRVO), Acurx Pharmaceuticals (ACXP), Imunon (IMNN), Phio Pharmaceuticals (PHIO), Sensei Biotherapeutics (SNSE), Flora Growth (FLGC), and TherapeuticsMD (TXMD). These companies are all part of the "pharmaceutical products" industry. Oragenics vs. Biomerica Trinity Biotech Cingulate CervoMed Acurx Pharmaceuticals Imunon Phio Pharmaceuticals Sensei Biotherapeutics Flora Growth TherapeuticsMD Oragenics (NYSE:OGEN) and Biomerica (NASDAQ:BMRA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, community ranking, dividends, valuation, earnings and profitability. Is OGEN or BMRA more profitable? Oragenics has a net margin of 0.00% compared to Biomerica's net margin of -100.52%. Biomerica's return on equity of -90.19% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets OragenicsN/A -2,087.95% -486.56% Biomerica -100.52%-90.19%-64.54% Which has more risk and volatility, OGEN or BMRA? Oragenics has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500. Comparatively, Biomerica has a beta of -0.98, meaning that its share price is 198% less volatile than the S&P 500. Do institutionals & insiders hold more shares of OGEN or BMRA? 18.7% of Oragenics shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 10.1% of Oragenics shares are owned by insiders. Comparatively, 15.0% of Biomerica shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor OGEN or BMRA? In the previous week, Oragenics and Oragenics both had 1 articles in the media. Oragenics' average media sentiment score of 0.00 equaled Biomerica'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oragenics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Biomerica 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation & earnings, OGEN or BMRA? Biomerica has higher revenue and earnings than Oragenics. Biomerica is trading at a lower price-to-earnings ratio than Oragenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOragenics$40K87.21-$20.66M-$7.07-0.04Biomerica$5.41M2.83-$5.98M-$0.34-2.46 Does the MarketBeat Community believe in OGEN or BMRA? Biomerica received 137 more outperform votes than Oragenics when rated by MarketBeat users. Likewise, 67.82% of users gave Biomerica an outperform vote while only 0.00% of users gave Oragenics an outperform vote. CompanyUnderperformOutperformOragenicsOutperform VotesNo VotesUnderperform Votes44100.00% BiomericaOutperform Votes13767.82% Underperform Votes6532.18% SummaryBiomerica beats Oragenics on 9 of the 13 factors compared between the two stocks. Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGEN vs. The Competition Export to ExcelMetricOragenicsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$3.49M$7.04B$5.77B$20.08BDividend YieldN/A2.87%4.78%3.65%P/E Ratio-0.045.7325.8234.36Price / Sales87.21312.55453.6615.65Price / CashN/A67.8344.0520.85Price / Book0.476.747.634.92Net Income-$20.66M$138.11M$3.18B$1.02B7 Day Performance-4.13%-2.54%-1.95%-1.05%1 Month Performance0.49%-2.00%-0.23%-1.09%1 Year PerformanceN/A-5.04%16.69%13.70% Oragenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGENOragenicsN/A$0.29+1.0%N/AN/A$3.45M$40,000.00-0.045Gap UpBMRABiomerica0.4744 of 5 stars$0.76+45.6%N/A-22.6%$13.95M$5.58M-2.2460Gap UpTRIBTrinity Biotech0.4003 of 5 stars$0.77-6.7%N/AN/A$13.95M$56.83M-0.34480CINGCingulate2.8593 of 5 stars$4.35-2.8%$16.00+268.2%+300.5%$13.95MN/A0.0020CRVOCervoMed3.6014 of 5 stars$2.22+0.2%$42.00+1,796.2%-84.3%$13.67M$7.14M0.004Analyst UpgradeNews CoverageACXPAcurx Pharmaceuticals3.2137 of 5 stars$0.76-1.5%$12.00+1,472.7%-73.5%$12.99MN/A-0.703Gap UpIMNNImunon2.3114 of 5 stars$0.90-0.3%$20.50+2,190.5%+70.2%$12.98M$500,000.00-0.4730Analyst ForecastNews CoverageGap UpPHIOPhio Pharmaceuticals3.3657 of 5 stars$1.81-4.3%$36.00+1,890.0%-75.3%$12.57MN/A-0.1710Analyst ForecastAnalyst RevisionNews CoverageSNSESensei Biotherapeutics4.4927 of 5 stars$0.47-3.0%$4.33+814.2%-41.1%$11.97MN/A-0.4040FLGCFlora Growth1.7622 of 5 stars$0.82-3.3%$5.00+507.5%-14.7%$11.88M$76.07M0.00280TXMDTherapeuticsMD0.445 of 5 stars$1.02-0.5%N/A-42.5%$11.71M$1.60M0.00420Gap Up Related Companies and Tools Related Companies Biomerica Competitors Trinity Biotech Competitors Cingulate Competitors CervoMed Competitors Acurx Pharmaceuticals Competitors Imunon Competitors Phio Pharmaceuticals Competitors Sensei Biotherapeutics Competitors Flora Growth Competitors TherapeuticsMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:OGEN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OGEN Stock Alerts